STRS Ohio’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

STRS Ohio’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-4,800	Closed	-$81K	–	2331
2020 Q4	$81K	Buy	+4,800	New	+$60.1K	﹤0.01%	1933
2017 Q1	–	Sell	-19,900	Closed	-$877K	–	1953
2016 Q4	$997K	Buy	19,900 +1,100	+6%	+$57.8K	﹤0.01%	850
2016 Q3	$986K	Sell	18,800 -3,700	-16%	-$177K	﹤0.01%	826
2016 Q2	$930K	Buy	22,500 +1,800	+9%	+$78.3K	﹤0.01%	853
2016 Q1	$841K	Buy	+20,700	New	+$711K	﹤0.01%	887
2015 Q3	–	Sell	-13,200	Closed	-$284K	–	1969
2015 Q2	$327K	Buy	+13,200	New	+$294K	﹤0.01%	1459
2014 Q1	–	Sell	-2,300	Closed	-$39.1K	–	1779
2013 Q4	$39K	Buy	+2,300	New	+$28.6K	﹤0.01%	1665

Other funds holding FPRX

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

STRS Ohio's FPRX Position: Q1 2021 in Review

STRS Ohio sold out of Five Prime Therapeutics, Inc. (FPRX) in Q1 2021, closing a stake of 4,800 shares — an estimated $81K sold.

STRS Ohio first reported a position in FPRX in Q4 2013 and held it in 7 quarters. The position peaked at $997K in Q4 2016. 147 funds tracked by Wall St. Rank hold FPRX as of Q1 2021.

STRS Ohio reported no remaining Five Prime Therapeutics, Inc. position as of Q1 2021 after selling out during the quarter.
STRS Ohio sold 4,800 Five Prime Therapeutics, Inc. shares in Q1 2021, an estimated $81K.
STRS Ohio first reported a position in Five Prime Therapeutics, Inc. in Q4 2013 and held it in 7 quarters.
STRS Ohio's Five Prime Therapeutics, Inc. position peaked at $997K in Q4 2016.
147 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q1 2021.

Based on STRS Ohio's 13F filing for Q1 2021, filed 23 Apr 2021.